Inventiva
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Inventiva and buy or sell other stocks, options, and ETFs commission-free!About IVA
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors.
CEOFrédéric Cren
CEOFrédéric Cren
Employees123
Employees123
HeadquartersDaix, Bourgogne-Franche-Comte
HeadquartersDaix, Bourgogne-Franche-Comte
Founded2011
Founded2011
Employees123
Employees123
IVA Key Statistics
Market cap170.66M
Market cap170.66M
Price-Earnings ratio-1.22
Price-Earnings ratio-1.22
Dividend yield—
Dividend yield—
Average volume34.72K
Average volume34.72K
High today$3.26
High today$3.26
Low today$3.17
Low today$3.17
Open price$3.25
Open price$3.25
Volume9.06K
Volume9.06K
52 Week high$5.05
52 Week high$5.05
52 Week low$2.22
52 Week low$2.22
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%